Abstract:OBJECTIVE:To compare the safety and effectiveness of two minimally invasive approaches for multi-vessel coronary revascularization.METHODS:From August 2014 to February 2017, 70 consecutive patients who underwent minimally invasive coronary artery bypass grafting in Peking University Third Hospital were randomly divided into two groups. In one group, 40 patients underwent staged-hybrid coronary revascularization (staged-HCR) treatment; in the other group, 30 patients underwent minimally invasive total arterial revascularization with bilateral internal thoracic artery (BITA). In staged -HCR group, the patients underwent minimally invasive direct coronary artery bypass grafting (MIDCAB) and percutaneous coronary intervention (PCI) procedure for treatment of multi-vessel disease. In BITA group, the patients underwent total arterial coronary artery bypass grafting with composite "Y" BITA graft. Preoperative and postoperative data of the two groups, including postoperative blood usage, mechanical ventilation time, domiciling duration in intensive care unit (ICU), major adverse cerebral and cardiovascular event (MACCE), and postoperative coronary angiography results were compared, in order to evaluate the safety and effectiveness of these surgical approaches.RESULTS:The preoperative characteristics of 70 patients in the two groups showed no significant difference. All the patients underwent successfully, elective minimally invasive multi-vessel coronary artery bypass grafting as scheduled preoperatively. Postoperative result showed the patients in staged-HCR group took advantages in less postoperative mechanical ventilation time [Staged-HCR group (11.2±8.7) h vs. BITA group (18.3±9.1) h, P=0.013], shorter domiciling duration in ICU [Staged-HCR group (26.29±4.05) h vs. BITA group (44.74±28.75) h, P=0.022], and less total drainage [Staged-HCR group (695.57±250.46) mL vs. BITA group (1 103.26±547.44) mL, P=0.03] than the patients in the group of minimally invasive total arterial revascularization with BITA. Postoperative in hospital coronary angiography showed satisfactory graft patency rates in both groups [97.5% in Staged-HCR group vs. 97.8% in BITA group]. No MACCE occurred in both groups during hospitalization.CONCLUSION:Staged-HCR is a feasible method for the treatment of multi-vessel revascularization involving right coronary artery. Minimally coronary revascularization with BITA is associated with superior long-term graft patency and it's recommended for patients who could not tolerate dual-antiplatelet therapy. This study shows that both minimally invasive surgical approaches are safe and effective for treatment of patients with multi-vessel coronary artery disease.

[Comparison of the Effects of Rapamycin-Eluting Stent Implantation and Coronary Artery Bypass Grafting in Treatment of Patients with Multi-Vessel Coronary Disease].

Short-term and Long-term Postoperative Safety of Off-Pump Versus On-Pump Coronary Artery Bypass Grafting for Coronary Heart Disease: A Meta-analysis for Randomized Controlled Trials.

Long-term Outcome Comparison of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery Treated by PCI or CABG

[Comparison of Rapamycin and Paclitaxel Eluting Stent in Patients with Multi-Vessel Coronary Disease].

ASSA13-15-7 Drug-Eluting Stenting Versus Coronary Artery Bypass Graft for Unprotected Left Main Coronary Artery Disease: A Meta-Analysis Based on Time-To-Event Data from Randomised Controlled Trials

[Comparison of Outcomes of Two Minimally Invasive Approaches for Multi-Vessel Coronary Revascularization].

Study of long-term safety and efficacy of domestic Firebird rapamycin-eluting stent

Long-Term Effects of Drug-Eluting Stents Versus Bare Metal Stents on Patients with Acute St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes of 3-Year Clinical Follow-Up

Ten-year comparative long-term outcomes of PCI versus CABG in multi-vessel coronary artery disease

Comparing clinical outcomes of hybrid coronary revascularization with open coronary artery bypass in patients with multi-vessels lesions

Clinical Contrast Investigation of Firebird and Cypher Rapamycin Eluting Stent

The Impact of Everolimus Versus Other Rapamycin Derivative-Eluting Stents on Clinical Outcomes in Patients with Coronary Artery Disease: A Meta-Analysis of 16 Randomized Trials

Long-term outcomes of synchronous carotid endarterectomy and coronary artery bypass grafting versus solely carotid endarterectomy.

Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease

Percutaneous Treatment with Drug-Eluting Stent Vs Bypass Surgery in Patients Suffering from Chronic Stable Angina with Multivessel Disease Involving Significant Proximal Stenosis in Left Anterior Descending Artery

Short and Intermediate Term Clinical Outcome of Sirolimus-Eluting Stent Implantation in Patients with ST-segment Elevation Myocardial Infarction

Twelve Months Clinical Outcome of Drug‐Eluting Stents Implantation or Coronary Artery Bypass Surgery for the Treatment of Diabetic Patients with Multivessel Disease

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis

Comparison of Long-Term Safety of Coronary Sirolimus-Eluting Stent with Bare Metal Stent Implantation in Patients with Multivessel Coronary Disease

TCT-837 Everolimus-eluting Versus Other Rapamycin Derivatives-Eluting Stents in Patients with Coronary Artery Disease: a Meta-Analysis of 16 Randomized Trials

A comparison between coronary artery bypass grafting surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease.